The STINGR284S mRNA-LNP approach can be used to restore STING expression and function in STING-deficient tumors in order to stimulate anti-tumor immune responses and directly kill the tumor cells (Figure 5C, Figure 6C, Figure 7, Figures S3C and S8C). The gene discussed is STING1; the disease is neoplasm.